Three papers
by Andreas Schepky
- C Alexander-White, D Bury, M Cronin, M Dent, E Hack, NJ Hewitt, G Kenna, J Naciff, G Ouedraogo, A Schepky, C Mahony, and C Europe. A 10-step framework for use of read-across (RAX) in next generation risk assessment (NGRA) for cosmetics safety assessment. Regul Toxicol Pharmacol 129 : 105094 (Mar 4, 2022). [abstract] [pubmed]
- D Bury, C Alexander-White, HJ Clewell, M Cronin, B Desprez, A Detroyer, J Firman, E Hack, NJ Hewitt, G Kenna, M Klaric, C Lester, C Mahony, G Ouedraogo, A Paini, A Schepky, , and AY Efremenko. New framework for a non-animal approach adequately assures the safety of cosmetic ingredients - A case study on caffeine. Regul Toxicol Pharmacol 123 : 104931 (Apr 24, 2021). [abstract] [pubmed]
- CA Ellison, KL Blackburn, PL Carmichael, HJ Clewell, MTD Cronin, B Desprez, SE Escher, SS Ferguson, S Grégoire, NJ Hewitt, HM Hollnagel, M Klaric, A Patel, S Salhi, A Schepky, BG Schmitt, JF Wambaugh, and A Worth. Challenges in working towards an internal threshold of toxicological concern (iTTC) for use in the safety assessment of cosmetics: Discussions from the Cosmetics Europe iTTC Working Group workshop. Regul Toxicol Pharmacol 103 : 63-72 (Apr 15, 2019). [abstract] [pubmed]